Biotech Invitation to presentation of BioArctic’s second quarter report for April – June 2026 on August 26 at 9:30 a.m. CEST August 19, 2026
Biotech Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia August 17, 2026
Biotech Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain August 16, 2026
Biotech argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis August 16, 2026
Biotech Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update August 12, 2026
Biotech Annexon Expands Vonaprument Phase 3 Program in Geographic Atrophy with Addition of Month 24 Dual Primary Endpoint Complementing Month 15 Primary Endpoint and Launch of Open-Label Extension Study August 12, 2026
Biotech Annexon Reports Second Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones August 12, 2026
Biotech Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement August 12, 2026
Search
Biotech
August 19, 2026
August 17, 2026
August 16, 2026
August 16, 2026
August 16, 2026
August 14, 2026
August 12, 2026
August 12, 2026
August 12, 2026
August 12, 2026
